Esperion Therapeutics (ESPR) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the CEO, marking the 11th virtual annual meeting and sixth year of current CEO's tenure.

• Chief Legal and Corporate Affairs Officer designated as meeting secretary; record date for voting set as March 31, 2026.

• Quorum confirmed with over 257 million shares outstanding and entitled to vote.

• Notice of meeting and proxy materials distributed via mail and internet; voting instructions provided for attendees.

Board and executive committee updates

• Two Class I directors, both current board members, nominated for re-election to serve until 2029.

Shareholder proposals

• Four proposals presented: election of directors, advisory vote on executive compensation, ratification of auditors, and amendment to stock option plan.

• Board unanimously recommended approval of all proposals.